Sociodemographic data |
Age |
+ |
+ |
+ |
Gender |
+ |
+ |
+ |
Chronic disease |
− |
− |
+ |
Social environment |
− |
− |
+ |
Level of education |
− |
− |
+ |
Data regarding the LMWH-thromboprophylaxis pathway |
Type of surgery |
+ |
+ |
+ |
Occurrence of complications |
− |
+ |
+ |
Day of operation |
+ |
+ |
+ |
Day of discharge from acute hospital |
+ |
+ |
+ |
Type of rehabilitation after stay in acute hospital |
+ |
+ |
+ |
Beginning and duration of rehabilitation |
+ |
+ |
+ |
Data regarding medication, thromboprophylaxis, and LMWH nonadherence |
Medicine(s) taken postsurgery |
− |
+ |
+ |
Frequency and form of application |
− |
+ |
+ |
Side effects of medicine |
− |
− |
+ |
Special side effects of LMWH including resulting days without LMWH |
− |
− |
+ |
Difficulties in using medicines |
− |
− |
+ |
Special difficulties in using LMWH including resulting days without LMWH |
− |
− |
+ |
Morisky questionnaire including documentation of resulting days without LMWH |
− |
− |
+ |
Balance of medicine |
− |
− |
+ |
Recommendation for duration of using LMWH during respective pathway |
− |
− |
+ |
Using daily injection during respective pathway |
− |
− |
+ |
Person administering syringes (self-injection or not) |
− |
− |
+ |
Days without LMWH during respective pathway |
− |
− |
+ |
Source of syringes during respective pathway |
− |
− |
+ |
Preference capsule |
− |
− |
+ |
Improvement of nonadherence by capsule |
− |
− |
+ |
Variables that could explain LMWH nonadherence |
Fear of thrombosis |
− |
− |
+ |
Assessment of limitation by thrombosis in daily life |
− |
− |
+ |
Estimated duration of thrombosis treatment |
− |
− |
+ |
Assessment of thrombosis prevention through movement and drinking |
− |
− |
+ |
Rating prevention of thrombosis by drugs |
− |
− |
+ |
Comparison of (1) movement/drinking with (2) drugs regarding the importance of thromboprophylaxis |
− |
− |
+ |